These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 2468905)
1. Effects of calcium channel blockade on cardiac repercussions of long-standing hypertension. Messerli FH J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S44-7. PubMed ID: 2468905 [TBL] [Abstract][Full Text] [Related]
2. Effects of antihypertensive therapy on hypertensive heart disease. Messerli FH; Kaesser UR; Losem CJ Circulation; 1989 Dec; 80(6 Suppl):IV145-50. PubMed ID: 2532079 [TBL] [Abstract][Full Text] [Related]
3. Reduction of left ventricular hypertrophy: how beneficial? Messerli FH; Aristizabal D; Soria F Am Heart J; 1993 May; 125(5 Pt 2):1520-4. PubMed ID: 8480623 [TBL] [Abstract][Full Text] [Related]
4. Left ventricular hypertrophy: impact of calcium channel blocker therapy. Messerli FH Am J Med; 1991 May; 90(5A):27S-31S. PubMed ID: 2039017 [TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy and antihypertensive therapy. Messerli FH; Oren S; Grossman E Drugs; 1988; 35 Suppl 5():27-33. PubMed ID: 2975215 [TBL] [Abstract][Full Text] [Related]
6. Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy. Frishman WH; Skolnick AE; Strom JA Circulation; 1989 Dec; 80(6 Suppl):IV151-61. PubMed ID: 2532080 [TBL] [Abstract][Full Text] [Related]
7. Selection of antihypertensive therapy: cardiac and extracardiac considerations. Messerli FH; Soria F Cardiology; 1992; 81(4-5):316-24. PubMed ID: 1301259 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular hypertrophy in hypertension. Dunn FG; Burns JM; Hornung RS Am Heart J; 1991 Jul; 122(1 Pt 2):312-5. PubMed ID: 1828935 [TBL] [Abstract][Full Text] [Related]
9. Left ventricular hypertrophy: should it be reduced? Messerli FH; Soria F; Aristizabal D Clin Cardiol; 1993 May; 16(5 Suppl 2):II15-20. PubMed ID: 8504585 [TBL] [Abstract][Full Text] [Related]
12. Left ventricular hypertrophy as a risk factor in hypertension. Balogun MO; Dunn FG Afr J Med Med Sci; 1996 Sep; 25(3):277-83. PubMed ID: 10457806 [TBL] [Abstract][Full Text] [Related]
13. Effects of antihypertensive agents on the left ventricle: clinical implications. Díez J; González A; López B; Ravassa S; Fortuño MA Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension. Palmieri V; Devereux RB Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398 [TBL] [Abstract][Full Text] [Related]
15. Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor. Messerli FH; Ketelhut R J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S7-13. PubMed ID: 7507540 [TBL] [Abstract][Full Text] [Related]
16. The importance of left ventricular hypertrophy in human hypertension. Kahan T J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028 [TBL] [Abstract][Full Text] [Related]
17. Significance of Beta-Blocker in Patients with Hypertensive Left Ventricular Hypertrophy and Myocardial Ischemia. Koracevic G; Mićić S; Stojanovic M; Bozinovic N; Simic D; Lović D; Krstic N; Tomašević RJ Curr Vasc Pharmacol; 2023; 21(2):81-90. PubMed ID: 36722475 [TBL] [Abstract][Full Text] [Related]